Literature DB >> 17823139

Diabetes drug pioglitazone (Actos): risk of fracture.

Reza Heidarpour Meymeh1, Eric Wooltorton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17823139      PMCID： PMC1976649          DOI： 10.1503/cmaj.071177

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

Review 1.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Authors:  Jacques P Brown; Robert G Josse
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

2.  Thiazolidinedione use and bone loss in older diabetic adults.

Authors:  Ann V Schwartz; Deborah E Sellmeyer; Eric Vittinghoff; Lisa Palermo; Beata Lecka-Czernik; Kenneth R Feingold; Elsa S Strotmeyer; Helaine E Resnick; Laura Carbone; Brock A Beamer; Seok Won Park; Nancy E Lane; Tamara B Harris; Steven R Cummings
Journal:  J Clin Endocrinol Metab       Date:  2006-04-11       Impact factor: 5.958
  2 in total
  10 in total

1.  Thiazolidinediones induce osteocyte apoptosis by a G protein-coupled receptor 40-dependent mechanism.

Authors:  Aleksandra Mieczkowska; Michel F Baslé; Daniel Chappard; Guillaume Mabilleau
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

2.  Cellular and molecular effects of thiazolidinediones on bone cells: a review.

Authors:  Guillaume Mabilleau; Daniel Chappard; Michel F Baslé
Journal:  Int J Biochem Mol Biol       Date:  2011-06-20

3.  Chronic Pancreatitis and Diabetes Mellitus.

Authors:  Yu Kuei Lin; Philip C Johnston; Karla Arce; Betul A Hatipoglu
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

Review 4.  Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis.

Authors:  Adrian T Billeter; Beatrice Reiners; Svenja E Seide; Pascal Probst; Eva Kalkum; Christian Rupp; Beat P Müller-Stich
Journal:  Hepatobiliary Surg Nutr       Date:  2022-10       Impact factor: 8.265

5.  MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema.

Authors:  Francine M Gregoire; Fang Zhang; Holly J Clarke; Thomas A Gustafson; Dorothy D Sears; Svetlana Favelyukis; James Lenhard; Dennis Rentzeperis; L Edward Clemens; Yi Mu; Brian E Lavan
Journal:  Mol Endocrinol       Date:  2009-04-23

6.  Effects of vitamin D combined with pioglitazone hydrochloride on bone mineral density and bone metabolism in Type 2 diabetic nephropathy.

Authors:  Ling-Xu Wang; Na Wang; Qing-Li Xu; Wei Yan; Li Dong; Bao-Lin Li
Journal:  Biosci Rep       Date:  2017-03-27       Impact factor: 3.840

7.  Wolfram Syndrome: A Case Report and Review of Clinical Manifestations, Genetics Pathophysiology, and Potential Therapies.

Authors:  N B Toppings; J M McMillan; P Y B Au; O Suchowersky; L E Donovan
Journal:  Case Rep Endocrinol       Date:  2018-04-18

Review 8.  Redefining the role of thiazolidinediones in the management of type 2 diabetes.

Authors:  Anthony H Barnett
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

9.  Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins.

Authors:  Elena Pavlova Filipova; Katya Hristova Uzunova; Toni Yonkov Vekov
Journal:  Diabetol Metab Syndr       Date:  2015-07-16       Impact factor: 3.320

10.  Comprehensive analysis of PPARγ agonist activities of stereo-, regio-, and enantio-isomers of hydroxyoctadecadienoic acids.

Authors:  Aya Umeno; Mami Sakashita; Sakiko Sugino; Kazutoshi Murotomi; Tsugumi Okuzawa; Naoki Morita; Kentaro Tomii; Yuko Tsuchiya; Kazuhiko Yamasaki; Masanori Horie; Kentaro Takahara; Yasukazu Yoshida
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.